HPTN Publications

Mcinziba A, Bock P, Hoddinott G, Seeley J, Bond V, Fidler S, Viljoen L . Managing household income and antiretroviral therapy adherence among people living with HIV in a low-income setting: a qualitative data from the HPTN 071 (PopART) trial in South Africa. AIDS Res Ther. 2023, 20: 54

McKay HS, Margolick JB, Martinez-Maza O, Lopez J, Phair J, Rappocciolo G, Denny TN, Magpantay LI, Jacobson LP, Bream JH . Multiplex assay reliability and long-term intra-individual variation of serologic inflammatory biomarkers. Cytokine. 2017, 90: 185-192

McKinstry LA, Zerbe A, Farrior J, Kurth AE, Stanton J, Li M, Elion R, Leider J, Branson B, El-Sadr WM, Hanscom B, for the HPTN 065 Study, Kurth A, Li Maoji . A Randomized-Controlled Trial of Computer-based Prevention Counseling for HIV-Positive Persons (HPTN 065). 2017

Melendez JH, Hardick J, Barnes M, Barnes P, Geddes CD, Gaydos CA . Molecular Characterization of Markers Associated With Antimicrobial Resistance in Neisseria gonorrhoeae Identified From Residual Clinical Samples. Sex Transm Dis. 2018, 45: 312-315

Metzger DS, Donnell D, Celentano DD, Jackson JB, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM, Chawarski M, Ruan Y, Richardson P, Shin K, Chen RY, Sugarman J, Dye BJ, Rose SM, Beauchamp G, Burns DN; HPTN 058 Protocol Team, Burns DN, HPTN 058 Protocol Team . Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine-Naloxone: HIV Prevention Trials Network 058. JAIDS. 2015, 68: 554-61

Meyer D, Lowensen K, Perrin N, et al, Diane Meyer ,Kelly Lowensen,Nancy Perrin,Ayana Moore,Shruti H. Mehta,Cheryl R. Himmelfarb,Thomas V. Inglesby,Jacky M. Jennings,Alexandra K. Mueller,Jessica N. LaRicci,Woudase Gallo,Adam P. Bocek,Jason E. Farley . An evaluation of the impact of social and structural determinants of health on forgone care during the COVID-19 pandemic in Baltimore, Maryland. PLoS One. 2024

Mgodi NM, Takuva S, Edupuganti S, Karuna S, Andrew P, Lazarus E, Garnett P, Shava E, Mukwekwerere PG, Karg C, Tindale I, Greene E, Luthuli N, Baepanye K, Hural J, Gomez Lorenzo MM, Burns D, Miner MD, Ledgerwood J, Mascola JR, Donnell D, Cohen MS, Corey L, HVTN 703/HPTN 081 Team . A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings. J Acquir Immune Defic Syndr. 2021, 87: 680-687

Miller L, Prieto Merino D, Baisley K, Hayes R. . Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV prevention.. PLoS One. , 17: e0267011